SPARSE DATA-ANALYSIS

被引:25
作者
AARONS, L
机构
[1] Pharmacy Department, University of Manchester, Manchester, M13 9PL, Oxford Road
关键词
SPARSE DATA ANALYSIS; POPULATION PHARMACOKINETICS; PHARMACODYNAMICS; NONMEM; DRUG DEVELOPMENT;
D O I
10.1007/BF03220012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years there has been a growing interest in techniques capable of analyzing sparse data, particularly gathered during Phase III clinical trials, and there is now pressure on manufacturers to obtain more kinetic and dynamic information from Phase III studies. Techniques for the analysis of sparse data are reviewed drawing on a number of examples taken from pharmacokinetic and pharmacodynamic experiments.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 30 条
[1]  
AARONS L, 1991, BRIT J CLIN PHARMACO, V32, P669
[2]   A POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIDAZOLAM IN THE RAT [J].
AARONS, L ;
MANDEMA, JW ;
DANHOF, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (05) :485-496
[3]   POPULATION PHARMACOKINETICS OF TOBRAMYCIN [J].
AARONS, L ;
VOZEH, S ;
WENK, M ;
WEISS, P ;
FOLLATH, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (03) :305-314
[4]   THE KINETICS OF FLURBIPROFEN IN SYNOVIAL-FLUID [J].
AARONS, L .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (03) :265-269
[5]   AN ALTERNATIVE 2 STAGE METHOD VIA THE EM-ALGORITHM FOR THE ESTIMATION OF POPULATION PHARMACOKINETIC PARAMETERS [J].
AMISAKI, T ;
TATSUHARA, T .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1988, 11 (05) :335-348
[6]  
BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195
[7]   SMOOTH NONPARAMETRIC MAXIMUM-LIKELIHOOD-ESTIMATION FOR POPULATION PHARMACOKINETICS, WITH APPLICATION TO QUINIDINE [J].
DAVIDIAN, M ;
GALLANT, AR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1992, 20 (05) :529-556
[8]   EVALUATION OF THEOPHYLLINE PHARMACOKINETICS IN A PEDIATRIC POPULATION USING MIXED EFFECTS MODELS [J].
DRISCOLL, MS ;
LUDDEN, TM ;
CASTO, DT ;
LITTLEFIELD, LC .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1989, 17 (02) :141-168
[9]  
Gibaldi M., 1982, PHARMACOKINETICS
[10]  
JOCHEMSEN R, 1992, NEW STRATEGIES DRUG, P127